AVDL - Avadel Pharmaceuticals Plc's (AVDL) CEO Greg Divis On Q3 2020 Results - Quick Version Earnings Call Transcript
Avadel Pharmaceuticals plc (AVDL) Q3 2020 Earnings Conference Call November 9, 2020 8:20 A.M. ET Company Participants Thomas McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Conference Call Participants David Amsellem - Piper Jaffray Paul Matthews - Stifel Oren Livnat - H.C. Wainwright & Co. Matt Kaplan - Ladenburg Thalmann Disclaimer: *NEW* We are providing this transcript version in a raw, machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. Presentation Operator [00:00:05] Greetings, welcome to AVADO Pharmaceutical's third quarter Twenty twenty earnings call at this time, all participants are not listed, only mode. A question and answer session will follow the formal presentation, if any, which require operators of the conference, please. Press star zero on your
For further details see:
Avadel Pharmaceuticals Plc's (AVDL) CEO Greg Divis On Q3 2020 Results - Quick Version Earnings Call Transcript